We are live on ! Find out more

297 hedge funds and large institutions have $8.35B invested in Genpact in 2021 Q2 according to their latest regulatory filings, with 47 funds opening new positions, 113 increasing their positions, 91 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 91

6% more capital invested

Capital invested by funds: $7.88B → $8.35B (+$472M)

4% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 45

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% less ownership

Funds ownership: 98.28%98.28% (-0%)

1% less funds holding

Funds holding: 299297 (-2)

5% less call options, than puts

Call options by funds: $1.65M | Put options by funds: $1.75M

Holders
297
Holders Change
-2
Holders Change %
-0.67%
% of All Funds
5.17%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.07%
New
47
Increased
113
Reduced
91
Closed
45
Calls
$1.65M
Puts
$1.75M
Net Calls
-$96K
Net Calls Change
+$337K

G Hedge Fund Activity: Q2 2021 in Review

297 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Genpact (G) for Q2 2021, worth a combined $8.35B — up 6% from $7.88B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new G positions and 45 closed out — a net gain of 2 holders — while 113 added to existing stakes and 91 trimmed.

The largest buyer was BlackRock, adding an estimated $237M. The largest seller was Fidelity Investments, cutting an estimated $327M.

  • 297 institutional investors held Genpact (G) as of Q2 2021, down from 299 in Q1 2021.
  • Funds reported $8.35B of Genpact stock for Q2 2021, up 6% quarter-over-quarter.
  • 47 funds opened new Genpact positions in Q2 2021 and 45 closed out, a net change of +2 holders.
  • The largest Genpact buyer in Q2 2021 was BlackRock, an estimated $237M added.
  • The largest Genpact seller in Q2 2021 was Fidelity Investments, an estimated $327M sold.

Based on aggregated 13F filings for Q2 2021.